New Treatment for Opioid-Induced Constipation

• Autores: Diane S. Aschenbrenner
• Localización: American Journal of Nursing, ISSN 0002-936X, Vol. 115, Nº. 1, 2015, págs. 23-23
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • * The opioid antagonist naloxegol (Movantik) is now approved to treat opioid-induced constipation in adults with chronic noncancer pain.

    * The most common adverse effects are abdominal pain, diarrhea, nausea, flatulence, vomiting, and headache.